-
Molecular Differences Between Left-Sided Colon and Rectal Cancers
Uncategorized
-
John L. Marshall, MD, on how checkpoint inhibitors are being integrated into treatment of GI cancers
Uncategorized
-
John L. Marshall, MD, discusses which molecular tests to order when determining treatment approach
Uncategorized
-
John L. Marshall, MD, on how to integrate genetic mutations into a treatment decision
Uncategorized
-
John L. Marshall, MD, tells us how vaccines can be used to broaden the use of immunotherapies
Uncategorized
-
John L. Marshall, MD, talks about the results of the RESORCE trial
Uncategorized
-
The Optimal Timing for Surgery After Neoadjuvant Chemotherapy in Advanced Gastric Cancer
Uncategorized
-
A Diagnosis No Young Person Expects
Matt Wixon was 39 years old and preparing for the birth of his first child when he was diagnosed with stage 4 colon cancer. While rates of colon cancer are declining among older adults, they are on the rise in people under age 50 – a troubling trend.
Category: News
-
All Over the Map When It Comes to Survivorship
Every survivor of a gastrointestinal cancer has unique follow-up needs. A road map for this process can help.
Category: News